Skip to main content

and
  1. Article

    Open Access

    Decreased HIV diversity after allogeneic stem cell transplantation of an HIV-1 infected patient: a case report

    The human immunodeficiency virus type 1 (HIV-1) coreceptor use and viral evolution were analyzed in blood samples from an HIV-1 infected patient undergoing allogeneic stem cell transplantation (SCT). Corecepto...

    Christel Kamp, Timo Wolf, Ignacio G Bravo, Benjamin Kraus in Virology Journal (2010)

  2. No Access

    Article

    HIV-1 replication in central nervous system increases over time on only protease inhibitor therapy

    There are concerns about central nervous system (CNS)-replication of HIV-1 in patients on boosted protease inhibitors. Purpose of this study was to compare HIV-1 viral loads (VLs) from patients treated with on...

    Maximilian Donath, Timo Wolf, Martin Stürmer in Medical Microbiology and Immunology (2016)

  3. No Access

    Article

    Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOV

    Recombinant vesicular stomatitis virus–Zaire Ebola virus (rVSV-ZEBOV) is the most advanced Ebola virus vaccine candidate and is currently being used to combat the outbreak of Ebola virus disease (EVD) in the D...

    Stefanie A. Ehrhardt, Matthias Zehner, Verena Krähling in Nature Medicine (2019)

  4. Article

    Open Access

    Dynamics and durability of HIV-1 neutralization are determined by viral replication

    Human immunodeficiency virus type 1 (HIV-1)-neutralizing antibodies (nAbs) that prevent infection are the main goal of HIV vaccine discovery. But as no nAb-eliciting vaccines are yet available, only data from ...

    Philipp Schommers, Dae Sung Kim, Maike Schlotz, Christoph Kreer in Nature Medicine (2023)